From: Becker's Supply Chain Report <>
Subject: Hyland's recalls teething products months after FDA warns of toxic substances | Adeptus Health files for bankruptcy | Valeant's plaque psoriasis drug to cost $3.5k a month | 4 latest FDA approvals
View our profile on LinkedIn Follow us on Twitter Like us on Facebook Find us on Google+ View our videos on YouTube

April 21, 2017
Adeptus Health files for bankruptcy 

2. Hyland's recalls teething products months after FDA warns of toxic substances 
Valeant's new plaque psoriasis drug to cost $3.5k per month

4. How can clinicians spend more time working with patient care and outcomes and less with supply, inventory and administrative tasks? Learn more in this upcoming webinar.  

Price hikes likely added $8.7B to pharma's net income for 2016, report finds   Full story

MACRA could cause $250B drop in hospital Medicare revenue by 2030

7. Is your ASC prepared to succeed with today's alternate payment models, such as value-based and shared savings models? Learn more in this upcoming webinar.

8. 4 latest FDA approvals   Full story
9. Nonprofit group fighting drug importation has deep ties to PhRMA   Full story
10. NIH employee charged with stealing medical research equipment, selling it on eBay  
9 latest hospital, health system CEO moves

Call for submissions - "Supply chain tip of the week": If you would like to contribute a tip, insight or best practice related to improving the hospital supply chain, please email Mackenzie Bean at

Contact Us

Editorial Contact: 
Molly Gamble 
(800) 417-2035
Sales, Marketing & Events:
Jessica Cole
President and CEO

Becker's Hospital Review
A Becker's Healthcare Publication
35 E. Wacker Drive, Suite 1782 | Chicago, IL 60601
Becker's Healthcare, 35 E. Wacker, Suite 1782, Chicago, IL 60601
Sent by in collaboration with
Constant Contact